Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic
A bone targeting nanosystem is reported here which combined magnetic contrast agent for Magnetic Resonance Imaging (MRI) and a therapeutic agent (bisphosphonates) into one drug delivery system. This new targeting nanoplatform consists of superparamagnetic γFe2O3 nanoparticles conjugated to 1,5-dihy...
Saved in:
Main Authors: | Y. Lalatonne, M. Monteil, H. Jouni, J. M. Serfaty, O. Sainte-Catherine, N. Lièvre, S. Kusmia, P. Weinmann, M. Lecouvey, L. Motte |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.4061/2010/747852 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Field switching of microfabricated metamagnetic FeRh MRI contrast agents
by: Stephen Dodd, et al.
Published: (2025-01-01) -
Optimized Synthesis and Stabilization of Superparamagnetic Iron Oxide Nanoparticles for Enhanced Biomolecule Adsorption
by: Wanderson Juvencio Keijok, et al.
Published: (2025-01-01) -
UTE MRI technical developments and applications in osteoporosis: a review
by: Soo Hyun Shin, et al.
Published: (2025-02-01) -
Diagnostic performance of contrast-enhanced T2-FLAIR MRI in the detection of meningitis
by: Sanjay P., et al.
Published: (2025-01-01) -
GSK-3𝜷: A Bifunctional Role in Cell Death Pathways
by: Keith M. Jacobs, et al.
Published: (2012-01-01)